2019-LB: The Characteristic Activity of Regulatory B Cells during the Occurrence and Development of Insulin Resistance

Introduction & Objective: To investigate the aberrant distribution and clinical relevance of regulatory B cells (Bregs) subsets in the peripheral blood of individuals with different levels of insulin resistance (IR). Methods: A cohort of 124 subjects were divided into five groups according to th...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 73; no. Supplement_1; p. 1
Main Authors WEI, LINGLING, ZHANG, LIJIE, MA, YAN, ZHAO, DONG, YANG, LONGYAN
Format Journal Article
LanguageEnglish
Published New York American Diabetes Association 14.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Introduction & Objective: To investigate the aberrant distribution and clinical relevance of regulatory B cells (Bregs) subsets in the peripheral blood of individuals with different levels of insulin resistance (IR). Methods: A cohort of 124 subjects were divided into five groups according to their insulin resistance index (HOMA-IR) and diabetes diagnosis. The groups comprised HOMA-IR<3 (IR- without T2DM), HOMA-IR<3 (IR- with T2DM), 3≤HOMA-IR<6 (IR+ without T2DM), 3≤HOMA-IR < 6 (IR+ without T2DM) and HOMA-IR≥6 (IR++ with T2DM). Peripheral blood samples were collected from each group, the percentages of CD19+CD24+CD27+ and CD19+CD24+CD38+ Bregs and the levels of IL-2, IL-4, IL-6, IL-10, IL-17, TNF-α, IFN-γ were detected by flow cytometry and flow microsphere matrix method. Additionally, the cytokines levels were validated through ELISA. The activation of Bregs and the production of IL-10 among different groups were analyzed. Spearman correlation analysis was used to analyze the correlation between Bregs activation rate and IR degree. Results: The results showed that the levels of CD19+CD24+CD27+ and CD19+CD24+CD38+ cells were increased whether in IR+ without or with T2DM groups compared to the IR- group, with the most significant increase observed in the IR++ with T2DM group. Moreover, the plasma levels of IL-6, IL-10, IL-17, TNF-α and IFN-γ in the IR+ group were higher than those in the IR- group. The expression and activation level of Bregs were positively correlated with the severity of IR in T2DM. Conclusion: These results suggest that the increase level of Bregs is closely related to the severity of IR, highlighting the potential significance of Bregs in the clinical progression of Type 2 Diabetes Mellitus (T2DM) and its associated insulin resistance.
AbstractList Introduction & Objective: To investigate the aberrant distribution and clinical relevance of regulatory B cells (Bregs) subsets in the peripheral blood of individuals with different levels of insulin resistance (IR). Methods: A cohort of 124 subjects were divided into five groups according to their insulin resistance index (HOMA-IR) and diabetes diagnosis. The groups comprised HOMA-IR<3 (IR- without T2DM), HOMA-IR<3 (IR- with T2DM), 3≤HOMA-IR<6 (IR+ without T2DM), 3≤HOMA-IR < 6 (IR+ without T2DM) and HOMA-IR≥6 (IR++ with T2DM). Peripheral blood samples were collected from each group, the percentages of CD19+CD24+CD27+ and CD19+CD24+CD38+ Bregs and the levels of IL-2, IL-4, IL-6, IL-10, IL-17, TNF-α, IFN-γ were detected by flow cytometry and flow microsphere matrix method. Additionally, the cytokines levels were validated through ELISA. The activation of Bregs and the production of IL-10 among different groups were analyzed. Spearman correlation analysis was used to analyze the correlation between Bregs activation rate and IR degree. Results: The results showed that the levels of CD19+CD24+CD27+ and CD19+CD24+CD38+ cells were increased whether in IR+ without or with T2DM groups compared to the IR- group, with the most significant increase observed in the IR++ with T2DM group. Moreover, the plasma levels of IL-6, IL-10, IL-17, TNF-α and IFN-γ in the IR+ group were higher than those in the IR- group. The expression and activation level of Bregs were positively correlated with the severity of IR in T2DM. Conclusion: These results suggest that the increase level of Bregs is closely related to the severity of IR, highlighting the potential significance of Bregs in the clinical progression of Type 2 Diabetes Mellitus (T2DM) and its associated insulin resistance.
Introduction & Objective: To investigate the aberrant distribution and clinical relevance of regulatory B cells (Bregs) subsets in the peripheral blood of individuals with different levels of insulin resistance (IR). Methods: A cohort of 124 subjects were divided into five groups according to their insulin resistance index (HOMA-IR) and diabetes diagnosis. The groups comprised HOMA-IR<3 (IR- without T2DM), HOMA-IR<3 (IR- with T2DM), 3≤HOMA-IR<6 (IR+ without T2DM), 3≤HOMA-IR < 6 (IR+ without T2DM) and HOMA-IR≥6 (IR++ with T2DM). Peripheral blood samples were collected from each group, the percentages of CD19+CD24+CD27+ and CD19+CD24+CD38+ Bregs and the levels of IL-2, IL-4, IL-6, IL-10, IL-17, TNF-α, IFN-γ were detected by flow cytometry and flow microsphere matrix method. Additionally, the cytokines levels were validated through ELISA. The activation of Bregs and the production of IL-10 among different groups were analyzed. Spearman correlation analysis was used to analyze the correlation between Bregs activation rate and IR degree. Results: The results showed that the levels of CD19+CD24+CD27+ and CD19+CD24+CD38+ cells were increased whether in IR+ without or with T2DM groups compared to the IR- group, with the most significant increase observed in the IR++ with T2DM group. Moreover, the plasma levels of IL-6, IL-10, IL-17, TNF-α and IFN-γ in the IR+ group were higher than those in the IR- group. The expression and activation level of Bregs were positively correlated with the severity of IR in T2DM. Conclusion: These results suggest that the increase level of Bregs is closely related to the severity of IR, highlighting the potential significance of Bregs in the clinical progression of Type 2 Diabetes Mellitus (T2DM) and its associated insulin resistance.
Author WEI, LINGLING
MA, YAN
ZHAO, DONG
ZHANG, LIJIE
YANG, LONGYAN
Author_xml – sequence: 1
  givenname: LINGLING
  surname: WEI
  fullname: WEI, LINGLING
– sequence: 2
  givenname: LIJIE
  surname: ZHANG
  fullname: ZHANG, LIJIE
– sequence: 3
  givenname: YAN
  surname: MA
  fullname: MA, YAN
– sequence: 4
  givenname: DONG
  surname: ZHAO
  fullname: ZHAO, DONG
– sequence: 5
  givenname: LONGYAN
  surname: YANG
  fullname: YANG, LONGYAN
BookMark eNotkMtqwzAQRUVJoUnaXT9A0G3djiQ_ou6S9BUwBEoW3QlZHicOjpxKciB_X5uEWdzNuWfgTsjIthYJeWTwwoXIXsuCxxEHJqN8cUPGTAoZCZ79jsgYgPGIZTK7IxPv9wCQ9jcmpyv-Rjc7pMuddtoEdLUPtaFzE-pTHc60regPbrtGh9ad6YIusWk8LTtX2y0NfXFtTOccWoNU25K-4wmb9nhAG4buyvquqW3v8L1Y99Q9ua104_HhmlOy-fzYLL-jfP21Ws7zyKRJEpWAcZVVSSIkS6uiZGiMTsuCGQAuEi4LLbhkMaIUFfCsELPEzIo4K9MiZjwTU_J00R5d-9ehD2rfds72H5VgAAJgxpKeer5QxrXeO6zU0dUH7c6KgRqGVcOwalhK5QvxDzHGbME
ContentType Journal Article
Copyright Copyright American Diabetes Association Jun 2024
Copyright_xml – notice: Copyright American Diabetes Association Jun 2024
DBID AAYXX
CITATION
K9.
NAPCQ
DOI 10.2337/db24-2019-LB
DatabaseName CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
DatabaseTitle CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
DatabaseTitleList CrossRef
ProQuest Health & Medical Complete (Alumni)
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1939-327X
ExternalDocumentID 10_2337_db24_2019_LB
Genre Conference Proceeding
GroupedDBID ---
.55
.XZ
08P
0R~
18M
29F
2WC
354
4.4
53G
5GY
5RE
5RS
5VS
6PF
8R4
8R5
AAFWJ
AAQQT
AAWTL
AAYEP
AAYXX
ABOCM
ACGFO
ACGOD
ACPRK
ADBBV
AEGXH
AENEX
AERZD
AHMBA
AIAGR
AIZAD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BES
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EDB
EMOBN
EX3
F5P
FRP
GX1
H13
HZ~
IAO
IEA
IHR
INH
INR
IOF
IPO
K2M
KQ8
L7B
M5~
O5R
O5S
O9-
OHH
OK1
OVD
P2P
PCD
Q2X
RHI
RPM
SJN
SV3
TDI
TEORI
TR2
VVN
W8F
WH7
WOQ
WOW
X7M
YFH
YHG
YOC
ZY1
~KM
K9.
NAPCQ
ID FETCH-LOGICAL-c655-d0e4f7f553916fbd1ecca6db1c0023529ba32914ee93f027b385c8b47d6b41273
ISSN 0012-1797
IngestDate Mon Jun 30 10:45:26 EDT 2025
Tue Jul 01 04:15:22 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue Supplement_1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c655-d0e4f7f553916fbd1ecca6db1c0023529ba32914ee93f027b385c8b47d6b41273
Notes ObjectType-Conference Proceeding-1
SourceType-Scholarly Journals-1
content type line 14
PQID 3100300815
PQPubID 34443
ParticipantIDs proquest_journals_3100300815
crossref_primary_10_2337_db24_2019_LB
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-06-14
PublicationDateYYYYMMDD 2024-06-14
PublicationDate_xml – month: 06
  year: 2024
  text: 2024-06-14
  day: 14
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
PublicationTitle Diabetes (New York, N.Y.)
PublicationYear 2024
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
SSID ssj0006060
Score 2.451899
Snippet Introduction & Objective: To investigate the aberrant distribution and clinical relevance of regulatory B cells (Bregs) subsets in the peripheral blood of...
SourceID proquest
crossref
SourceType Aggregation Database
Index Database
StartPage 1
SubjectTerms Beta cells
Blood levels
CD19 antigen
CD27 antigen
CD38 antigen
Correlation analysis
Diabetes
Diabetes mellitus (non-insulin dependent)
Flow cytometry
Insulin resistance
Interleukin 10
Interleukin 17
Interleukin 6
Peripheral blood
Plasma levels
Tumor necrosis factor-α
γ-Interferon
Title 2019-LB: The Characteristic Activity of Regulatory B Cells during the Occurrence and Development of Insulin Resistance
URI https://www.proquest.com/docview/3100300815
Volume 73
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwELYKSIgL4rXiLR_ghLLbOHaacEvLo0VtkVZdLbeodpwTKogWDvx6ZvxoUtQDcImqKHYjzxfPw_PNEHI2jsaqFKrE8JIKOCiEIEk4C8C9jSRXTLAUycmDYdz9x-8exEOj8Vpnl8zkb_W-lFfyE6nCPZArsmS_Idn5pHADfoN84QoShuuXZAxqNQ36bZ850VkovnyRKdcZwtQbMS3n8UC9fdHRj49TT1BEwxNLDb_YcrM2M3meSGSZJjZd_a-eorHpUeIs2qta8PZzW59amOH_dc-EAHrD274vYoXx6m5mSVP93l1vTooYZEYzZMPaY_dmd7x3Q12cgnHMp7L8UL_3hgyLobbqe69tY-IwZvqYmqBoHi7b3Vlk6gMUEiZ3C1xpMX9y_0m5zVMOwdnB8TmOznF03m-vkDUG3gXzQR6nwMGns8wl98KWL4Gj_9T_e9GSWVTkxjoZbZFN51bQzGJkmzT0ZIesD1zixC55c7NdUgAKXQQK9UChTyWtgELb1ACFWqBQAAqtgEIBKLQGFBzrgEIroOyR0c31qNMNXMuNQMVCBEVT87JVCoF07FIWIX7gcSFDZeoisVSOI5aGXOs0KpusJaNEqETyVhFLHoIl_IusTp4mep_QBCZKOTwSC2QgSRknrNBcFoo10Sk_IOd-9fJnW1glXyajA3LslzZ3n940x1OpCK1ZcfjFaY7IRgXKY7I6e3nVJ2BOzuSpEf4HFA1vsA
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2019-LB%3A+The+Characteristic+Activity+of+Regulatory+B+Cells+during+the+Occurrence+and+Development+of+Insulin+Resistance&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=WEI%2C+LINGLING&rft.au=ZHANG%2C+LIJIE&rft.au=MA%2C+YAN&rft.au=ZHAO%2C+DONG&rft.date=2024-06-14&rft.issn=0012-1797&rft.volume=73&rft.issue=Supplement_1&rft_id=info:doi/10.2337%2Fdb24-2019-LB&rft.externalDBID=n%2Fa&rft.externalDocID=10_2337_db24_2019_LB
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon